title: Impetigo herpetiformis with gestational hypertension: a case report and literature review.
abstract: BACKGROUND
  Impetigo herpetiformis (IH) is a rare skin disorder that occurs during pregnancy. It was previously associated with high maternal and fetal mortality and morbidity, but now has a better prognosis.
  
  
  METHODS
  We report a case of a pregnant woman with IH who presented with generalized erythematous pustular eruptions in the 32nd week of gestation. The IH progressed rapidly, and gestational hypertension was observed in the 36th week. The lesions did not subside, despite treatment with corticosteroids and phototherapy. She delivered a healthy male baby via cesarean section in the 37th week. One month after her delivery, her skin returned to normal, except for residual pigmentation, with complete recovery 3 months postpartum.
  
  
  CONCLUSIONS
  An experienced medical team comprising obstetricians, dermatologists, perinatologists and neonatologists is critical to aggressively treat this life-threatening specific dermatosis of pregnancy and to prevent ensuing complications, such as fluid and electrolyte imbalance, secondary infection and placental insufficiency.
authors.affiliation: Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taipei, Taiwan, ROC.
authors.forename: Y H
authors.initials: YH
authors.lastname: Huang
authors.forename: Y P
authors.initials: YP
authors.lastname: Chen
authors.forename: C C
authors.initials: CC
authors.lastname: Liang
authors.forename: Y L
authors.initials: YL
authors.lastname: Chang
authors.forename: C C
authors.initials: CC
authors.lastname: Hsieh
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D002585:Cesarean Section; D016572:Cyclosporine / Q000627:therapeutic use; D003874:Dermatitis Herpetiformis / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D003879:Dermatologic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D046110:Hypertension, Pregnancy-Induced / Q000175:diagnosis* / Q000188:drug therapy; D007169:Impetigo / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D007231:Infant, Newborn; D050498:Live Birth; D008297:Male; D010789:Phototherapy; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis* / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D003879:Dermatologic Agents; D016572:Cyclosporine; D002118:Calcium